了解癌症休眠的过程,而不是战略性的连接机制与技术的理解
Sumin Yang1, Jieun Seo2,3, Jeonghyeon Choi1
1Department of Pharmacy, College of Pharmacy, Hanyang University, Ansan, Gyeonggi-do, 15588, Korea.
Molecular cancer
|February 14, 2025
概括
癌症休眠期允许静止细胞生存,并可能导致致命的复发. 预计先进的测序和人工智能将揭示导致癌症复发的复杂机制.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 遗传学 是一个遗传学.
背景情况:
- 癌症休眠期是初始治疗后致命癌症复发的关键因素.
- 静止的癌细胞可以持续不被检测,经历遗传/表观遗传改变.
- 癌症休眠期涉及从传播到殖民的复杂级联,受基因调节的影响.
研究的目的:
- 为了探索癌症休眠的多面性质.
- 了解潜伏癌症状态背后的细胞和分子机制.
- 为突出精确定义和可视化癌症休眠期所面临的挑战.
主要方法:
- 关于癌症休眠期的现有文献的综述.
- 讨论参与休眠的细胞过程 (例如静止,遗传/表观遗传变化).
- 强调新兴技术,如单细胞和长读测序.
主要成果:
- 癌症休眠期是一种动态状态,受各种条件的影响,包括药物治疗.
- 休眠过程涉及多个步骤:传播,入侵,循环,免疫逃避和殖民.
- 基因调节在控制休眠癌细胞的命运方面发挥着重要作用.
结论:
- 对癌症休眠期的全面理解仍然是难以捉摸的.
- 先进的单细胞和长读测序,再加上人工智能,为阐明癌症休眠期提供了有希望的工具.
- 预计这些技术将为癌症休眠期的各个方面提供整体的了解.
更多相关视频
08:48An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation
Published on: June 30, 2015
8.2K
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
10.5K
相关概念视频
Cancer Stem Cells and Tumor Maintenance
4.7K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.7K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Cancer Survival Analysis
321
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
321
Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
